Latest On ARCA biopharma, Inc (ABIO):
About ARCA biopharma, Inc (ABIO):
ARCA biopharma, Inc. operates as a biopharmaceutical company applying a precision medicine approach to developing and commercializing genetically targeted therapies for cardiovascular diseases. Its lead product candidate, Gencaro (bucindolol hydrochloride) is pharmacogenetically-targeted beta-adrenergic receptor antagonist, which is in the development for the treatment of atrial fibrillation in certain patients who also have heart failure (HF). The company also engages in the development of AB171, a thiol-substituted isosorbide mononitrate for the treatment of HF and peripheral arterial disease. ARCA biopharma, Inc. is headquartered in Westminster, Colorado.
General
- Name ARCA biopharma, Inc
- Symbol ABIO
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 13
- Last Split Factor1:18
- Last Split Date2019-04-04
- Fiscal Year EndDecember
- IPO Date1997-08-08
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://arcabio.com
Valuation
- Price/Book (Most Recent Quarter) 0.77
- Enterprise Value EBITDA 2.16
Financials
- Most Recent Quarter 2020-09-30
- Return on Assets -12%
- Return on Equity -20%
- Earnings Per Share -$6.67
- Revenue Per Share $0
- Quarterly Earnings Growth 0%
Highlights
- Market Capitalization 37.85 million
- EBITDA -6456000
- Analyst Target Price $7
- Book Value Per Share $5.43
Share Statistics
- Shares Outstanding 9.32 million
- Shares Float 9.28 million
- % Held by Insiders 40%
- % Held by Institutions 8.43%
- Shares Short 197614
- Shares Short Prior Month 119719
- Short Ratio 0.13
- Short % of Float 2%
- Short % of Shares Outstanding 2%
Technicals
- Beta 2.77
- 52 Week High $10.25
- 52 Week Low $2.51
- 50 Day Moving Average 4.51
- 200 Day Moving Average 4.36
Dividends
- Dividend Date 2019-04-04
- ExDividend Date N/A
- Dividend Yield 0%
ARCA biopharma, Inc (ABIO) Dividend Calendar:
ABIO's last dividend payment was made to shareholders on April 4, 2019.
Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
---|
ARCA biopharma, Inc (ABIO) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
---|---|---|---|---|---|
2020-09-30 | 2020-11-02 | $N/A | -$0.33 | ||
2020-06-30 | 2020-08-05 | $N/A | -$0.73 | -$2.58 | 71.71% |
2020-03-31 | 2020-05-06 | $N/A | -$0.83 | -$2.04 | 59.31% |
2019-12-31 | 2020-02-18 | $N/A | -$0.69 | -$0.99 | 30.3% |
2019-09-30 | 2019-11-06 | $N/A | -$0.76 | -$1.30 | 41.54% |
2019-06-30 | 2019-08-01 | $N/A | -$1.14 | -$1.86 | 38.71% |
2019-03-31 | 2019-05-08 | $N/A | -$1.86 | -$1.98 | 6.06% |
2018-12-31 | 2019-02-27 | $N/A | -$1.80 | -$2.52 | 28.57% |
2018-09-30 | 2018-11-14 | $N/A | -$1.98 | -$3.42 | 42.11% |
2018-06-30 | 2018-08-09 | $N/A | -$2.70 | -$3.96 | 31.82% |
2018-03-31 | 2018-05-08 | $N/A | -$3.60 | -$3.60 | 0% |
2017-12-31 | 2018-03-22 | $N/A | -$6.12 | -$9.36 | 34.62% |
2017-09-30 | 2017-11-09 | $N/A | -$7.02 | ||
2017-06-30 | 2017-08-03 | $N/A | -$10.66 | ||
2017-03-31 | 2017-05-15 | $N/A | -$8.59 | ||
2016-12-31 | 2017-03-21 | $N/A | -$8.41 | ||
2016-09-30 | 2016-11-14 | $N/A | -$9.25 | ||
2016-06-30 | 2016-08-09 | $N/A | -$7.73 | ||
2016-03-31 | 2016-05-11 | $N/A | -$7.25 | ||
2015-12-31 | 2016-03-17 | $N/A | -$6.30 | ||
2015-09-30 | 2015-11-13 | $N/A | -$5.61 | ||
2015-06-30 | 2015-08-12 | $N/A | -$12.38 | ||
2015-03-31 | 2015-05-13 | $N/A | -$16.33 | ||
2014-12-31 | 2015-03-20 | $N/A | -$15.55 | ||
2014-09-30 | 2014-11-13 | $N/A | -$13.69 | ||
2014-06-30 | 2014-08-14 | $N/A | -$14.42 | ||
2014-03-31 | 2014-05-14 | $N/A | -$16.02 | ||
2013-12-31 | 2014-03-21 | $N/A | -$23.66 | ||
2013-09-30 | 2013-11-13 | $N/A | -$20.04 | ||
2013-06-30 | 2013-08-14 | $N/A | -$82.19 | ||
2013-03-31 | 2013-05-14 | $N/A | -$44.47 | ||
2012-12-31 | 2013-02-28 | $N/A | -$47.60 | ||
2012-09-30 | 2012-11-02 | $N/A | -$51.15 | ||
2012-06-30 | 2012-08-07 | $N/A | -$71.21 | ||
2012-03-31 | 2012-05-08 | $N/A | -$87.43 | ||
2011-12-31 | 2012-03-01 | $N/A | -$122.76 | ||
2011-09-30 | 2011-10-28 | $N/A | -$131.19 | ||
2011-06-30 | 2011-08-09 | $N/A | $21.68 | ||
2011-03-31 | 2011-05-10 | $N/A | -$188.77 | ||
2010-12-31 | 2011-03-03 | $N/A | -$141.76 | ||
2010-09-30 | 2010-10-29 | $N/A | -$180.56 | ||
2010-06-30 | 2010-08-10 | $N/A | -$196.51 | ||
2010-03-31 | 2010-05-11 | $N/A | -$242.32 | ||
2009-12-31 | 2010-02-25 | $N/A | -$659.39 | ||
2009-09-30 | 2009-10-30 | $N/A | -$429.88 | ||
2009-06-30 | 2009-08-11 | $N/A | -$858.09 | ||
2009-03-31 | 2009-05-08 | $N/A | $965.51 | ||
2008-12-31 | 2009-02-26 | $15.25 million | -$103,560.84 | ||
2008-09-30 | 2008-10-30 | $N/A | -$2,419.20 | -$2,872.80 | 15.79% |
2008-06-30 | 2008-07-23 | $N/A | -$82,015.77 | -$2,721.60 | -2913.51% |
2008-03-31 | 2008-05-08 | $N/A | -$5,140.80 | -$4,536.00 | -13.33% |
2007-12-31 | 2008-02-27 | $46.86 million | -$3,326.40 | -$4,006.80 | 16.98% |
2007-09-30 | 2007-11-01 | $N/A | -$4,082.40 | -$3,723.30 | -9.64% |
2007-06-30 | 2007-08-01 | $N/A | $8,164.80 | -$4,300.80 | 289.84% |
2007-03-31 | 2007-05-09 | $N/A | -$4,384.80 | -$4,460.40 | 1.69% |
2006-12-31 | 2007-02-27 | -$6,199.20 | -$6,598.80 | 6.06% | |
2006-09-30 | 2006-11-02 | -$7,711.20 | -$5,670.00 | -36% | |
2006-06-30 | 2006-08-03 | -$5,443.20 | -$5,644.80 | 3.57% | |
2006-03-31 | 2006-05-05 | -$6,048.00 | -$4,418.40 | -36.88% | |
2005-12-31 | 2006-02-27 | -$7,408.80 | -$7,063.20 | -4.89% | |
2005-09-30 | 2005-11-01 | -$6,652.80 | -$6,559.75 | -1.42% | |
2005-06-30 | 2005-08-04 | -$6,048.00 | -$6,615.00 | 8.57% | |
2005-03-31 | 2005-05-02 | -$5,896.80 | -$6,091.20 | 3.19% | |
2004-12-31 | 2005-02-15 | -$6,048.00 | -$9,256.80 | 34.66% | |
2004-09-30 | 2004-11-09 | -$5,140.80 | -$4,968.00 | -3.48% | |
2004-06-30 | 2004-08-09 | -$5,140.80 | -$5,473.44 | 6.08% | |
2004-03-31 | 2004-05-06 | -$9,828.00 | -$5,292.00 | -85.71% | |
2003-12-31 | 2004-02-05 | -$5,443.20 | -$5,216.40 | -4.35% | |
2003-09-30 | 2003-10-30 | -$7,711.20 | -$4,989.60 | -54.55% | |
2003-06-30 | 2003-07-31 | -$8,164.80 | -$9,979.20 | 18.18% | |
2003-03-31 | 2003-05-01 | -$12,410.53 | |||
2002-09-30 | 2002-10-24 | -$2,876.42 | |||
2002-06-30 | 2002-07-25 | -$16,590.15 | |||
2002-03-31 | 2002-04-25 | -$45,913.37 | |||
2001-12-31 | 2002-02-06 | -$27,664.40 | |||
2001-09-30 | 2001-10-25 | -$26,839.19 | |||
2001-06-30 | 2001-06-30 | -$24,866.74 | |||
2001-03-31 | 2001-03-31 | -$22,046.91 | |||
2000-12-31 | 2000-12-31 | -$22,222.22 | |||
2000-09-30 | 2000-10-26 | -$13,608.00 | -$17,236.80 | 21.05% | |
1999-12-31 | 2000-02-03 | -$17,690.40 | -$18,597.60 | 4.88% | |
1999-09-30 | 1999-11-02 | -$14,968.80 | -$17,236.80 | 13.16% | |
1998-12-31 | 1999-02-11 | -$14,968.80 | -$11,793.60 | -26.92% | |
1998-09-30 | 1998-10-29 | -$19,051.20 | -$11,566.80 | -64.71% | |
1998-06-30 | 1998-07-30 | -$14,061.60 | -$12,020.40 | -16.98% | |
1998-03-31 | 1998-04-30 | -$9,525.60 | -$11,793.60 | 19.23% | |
1997-12-31 | 1998-02-02 | -$5,443.20 | -$8,164.80 | 33.33% | |
1997-09-30 | 1997-10-21 | -$6,804.00 | -$5,670.00 | -20% |
ARCA biopharma, Inc (ABIO) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
Date |
---|
Research Development |
Income Before Tax |
Selling General Administrative |
Gross Profit |
Ebit |
Operating Income |
Income Tax Expense |
Total Revenue |
Cost of Revenue |
Total Other Income Expense Net |
Net Income From Continuing Operations |
Net Income Applicable to Common Shares |
Cash Flow:
Date |
---|
Investments |
Change to Liabilities |
Total Cash Flow from Investing Activities |
Net Borrowings |
Total Cash Flow from Financial Activities |
Change to Operating Activities |
Change in Cash |
Total Cash from Operating Activities |
Depreciation |
Other Cash Flow from Investing Activities |
Change to Inventory |
Change to Account Receivables |
Other Cash Flow from Financing Activities |
Change to Net Income |
Capital Expenditures |
Balance Sheet:
Date |
---|
Total Liabailities |
Total Stockholder Equity |
Other Current Liabilities |
Total Assets |
Common Stock |
Other Current Assets |
Retained Earnings |
Other Liabilities |
Other Assets |
Cash |
Total Current Liabilities |
Other Stockholder Equity |
Property, Plant & Equipment |
Total Current Assets |
Long Term Investments |
Net Tangible Assets |
Short Term Investments |
Long Term Debt |
Inventory |
Accounts Payable |
ARCA biopharma, Inc (ABIO) Chart:
ARCA biopharma, Inc (ABIO) News:
Below you will find a list of latest news for ARCA biopharma, Inc (ABIO) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
ARCA biopharma, Inc (ABIO) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
---|
Latest ABIO Trades:
Date | Shares | Price |
---|---|---|
Jun 13, 2022 1:50 PM EST | 26 | $2.3 |
Jun 13, 2022 1:50 PM EST | 74 | $2.3 |
ARCA biopharma, Inc (ABIO) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
Date | Form Type | Form Name | Link |
---|---|---|---|
2020-07-02 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/907654/000156459020031694/0001564590-20-031694-index.htm |
2020-05-14 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/907654/000000000020004302/0000000000-20-004302-index.htm |
2018-02-05 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/907654/000003877718000045/0000038777-18-000045-index.htm |
2018-03-08 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/907654/000003877718000149/0000038777-18-000149-index.htm |
2019-02-12 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/907654/000103738919000002/0001037389-19-000002-index.htm |
2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/907654/000103738920000132/0001037389-20-000132-index.htm |
2018-03-05 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/907654/000107261318000184/0001072613-18-000184-index.htm |
2018-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/907654/000110465918008484/0001104659-18-008484-index.htm |
2018-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/907654/000110465918009147/0001104659-18-009147-index.htm |
2019-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/907654/000110465919007350/0001104659-19-007350-index.htm |
2020-01-24 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/907654/000110465920006493/0001104659-20-006493-index.htm |
2018-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/907654/000114420418009015/0001144204-18-009015-index.htm |
2018-04-18 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/907654/000119312518120604/0001193125-18-120604-index.htm |
2018-04-18 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/907654/000119312518120614/0001193125-18-120614-index.htm |
2018-09-10 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/907654/000119312518270139/0001193125-18-270139-index.htm |
2018-09-20 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/907654/000119312518278722/0001193125-18-278722-index.htm |
2019-01-25 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/907654/000119312519017177/0001193125-19-017177-index.htm |
2019-03-11 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/907654/000119312519070964/0001193125-19-070964-index.htm |
2019-05-09 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/907654/000119312519143045/0001193125-19-143045-index.htm |
2019-05-20 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/907654/000119312519151798/0001193125-19-151798-index.htm |
2019-06-28 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/907654/000119312519186177/0001193125-19-186177-index.htm |
2020-02-26 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/907654/000119312520050219/0001193125-20-050219-index.htm |
2020-05-07 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/907654/000119312520136266/0001193125-20-136266-index.htm |
2020-05-18 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/907654/000119312520145073/0001193125-20-145073-index.htm |
2020-06-03 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/907654/000119312520159219/0001193125-20-159219-index.htm |
2018-02-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/907654/000120919118013927/0001209191-18-013927-index.htm |
2018-02-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/907654/000120919118013928/0001209191-18-013928-index.htm |
2018-02-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/907654/000120919118013931/0001209191-18-013931-index.htm |
2018-02-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/907654/000120919118013932/0001209191-18-013932-index.htm |
2018-02-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/907654/000120919118013935/0001209191-18-013935-index.htm |
2018-02-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/907654/000120919118013936/0001209191-18-013936-index.htm |
2018-02-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/907654/000120919118013937/0001209191-18-013937-index.htm |
2018-02-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/907654/000120919118013939/0001209191-18-013939-index.htm |
2018-02-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/907654/000120919118013940/0001209191-18-013940-index.htm |
2018-02-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/907654/000120919118013942/0001209191-18-013942-index.htm |
2018-03-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/907654/000120919118015074/0001209191-18-015074-index.htm |
2018-03-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/907654/000120919118015077/0001209191-18-015077-index.htm |
2018-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/907654/000120919118016685/0001209191-18-016685-index.htm |
2018-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/907654/000120919118016689/0001209191-18-016689-index.htm |
2018-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/907654/000120919118016691/0001209191-18-016691-index.htm |
2018-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/907654/000120919118016693/0001209191-18-016693-index.htm |
2018-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/907654/000120919118016698/0001209191-18-016698-index.htm |
2018-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/907654/000120919118023118/0001209191-18-023118-index.htm |
2018-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/907654/000120919118023122/0001209191-18-023122-index.htm |
2020-09-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/907654/000120919120051302/0001209191-20-051302-index.htm |
2020-09-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/907654/000120919120051890/0001209191-20-051890-index.htm |
2020-09-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/907654/000120919120052094/0001209191-20-052094-index.htm |
2020-06-10 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/907654/000138713120005573/0001387131-20-005573-index.htm |
2018-02-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/907654/000145817718000001/0001458177-18-000001-index.htm |
2020-06-01 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/907654/000153561020000096/0001535610-20-000096-index.htm |
2018-01-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/907654/000156459018000237/0001564590-18-000237-index.htm |
2018-02-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/907654/000156459018003257/0001564590-18-003257-index.htm |
2018-03-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/907654/000156459018004399/0001564590-18-004399-index.htm |
2018-03-22 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/907654/000156459018006566/0001564590-18-006566-index.htm |
2018-03-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/907654/000156459018006579/0001564590-18-006579-index.htm |
2018-04-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/907654/000156459018008254/0001564590-18-008254-index.htm |
2018-04-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/907654/000156459018008752/0001564590-18-008752-index.htm |
2018-05-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/907654/000156459018011830/0001564590-18-011830-index.htm |
2018-05-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/907654/000156459018011864/0001564590-18-011864-index.htm |
2018-05-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/907654/000156459018014531/0001564590-18-014531-index.htm |
2018-06-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/907654/000156459018015077/0001564590-18-015077-index.htm |
2018-07-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/907654/000156459018018114/0001564590-18-018114-index.htm |
2018-08-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/907654/000156459018021065/0001564590-18-021065-index.htm |
2018-08-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/907654/000156459018021090/0001564590-18-021090-index.htm |
2018-09-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/907654/000156459018023272/0001564590-18-023272-index.htm |
2018-10-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/907654/000156459018024081/0001564590-18-024081-index.htm |
2018-10-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/907654/000156459018024466/0001564590-18-024466-index.htm |
2018-11-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/907654/000156459018029560/0001564590-18-029560-index.htm |
2018-11-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/907654/000156459018029594/0001564590-18-029594-index.htm |
2018-12-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/907654/000156459018031208/0001564590-18-031208-index.htm |
2019-01-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/907654/000156459019001155/0001564590-19-001155-index.htm |
2019-02-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/907654/000156459019003354/0001564590-19-003354-index.htm |
2019-02-27 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/907654/000156459019004882/0001564590-19-004882-index.htm |
2019-02-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/907654/000156459019004936/0001564590-19-004936-index.htm |
2019-03-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/907654/000156459019007204/0001564590-19-007204-index.htm |
2019-03-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/907654/000156459019008641/0001564590-19-008641-index.htm |
2019-04-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/907654/000156459019010715/0001564590-19-010715-index.htm |
2019-04-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/907654/000156459019010923/0001564590-19-010923-index.htm |
2019-04-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/907654/000156459019012247/0001564590-19-012247-index.htm |
2019-05-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/907654/000156459019017210/0001564590-19-017210-index.htm |
2019-05-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/907654/000156459019017283/0001564590-19-017283-index.htm |
2019-05-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/907654/000156459019017999/0001564590-19-017999-index.htm |
2019-05-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/907654/000156459019019829/0001564590-19-019829-index.htm |
2019-06-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/907654/000156459019024070/0001564590-19-024070-index.htm |
2019-08-01 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/907654/000156459019027966/0001564590-19-027966-index.htm |
2019-08-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/907654/000156459019028011/0001564590-19-028011-index.htm |
2019-10-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/907654/000156459019036859/0001564590-19-036859-index.htm |
2019-10-25 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/907654/000156459019037938/0001564590-19-037938-index.htm |
2019-10-25 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/907654/000156459019037939/0001564590-19-037939-index.htm |
2019-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/907654/000156459019041036/0001564590-19-041036-index.htm |
2019-11-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/907654/000156459019041051/0001564590-19-041051-index.htm |
2019-12-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/907654/000156459019045742/0001564590-19-045742-index.htm |
2020-02-18 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/907654/000156459020005032/0001564590-20-005032-index.htm |
2020-02-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/907654/000156459020005048/0001564590-20-005048-index.htm |
2020-03-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/907654/000156459020008703/0001564590-20-008703-index.htm |
2020-05-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/907654/000156459020021946/0001564590-20-021946-index.htm |
2020-05-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/907654/000156459020021999/0001564590-20-021999-index.htm |
2020-05-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/907654/000156459020027369/0001564590-20-027369-index.htm |
2020-06-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/907654/000156459020027745/0001564590-20-027745-index.htm |
2020-06-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/907654/000156459020028159/0001564590-20-028159-index.htm |
2020-07-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/907654/000156459020031680/0001564590-20-031680-index.htm |
2020-07-02 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/907654/000156459020031694/0001564590-20-031694-index.htm |
2020-07-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/907654/000156459020032355/0001564590-20-032355-index.htm |
2020-07-14 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/907654/000156459020032360/0001564590-20-032360-index.htm |
2020-07-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/907654/000156459020033048/0001564590-20-033048-index.htm |
2020-07-22 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/907654/000156459020033060/0001564590-20-033060-index.htm |
2020-08-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/907654/000156459020036784/0001564590-20-036784-index.htm |
2020-08-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/907654/000156459020036857/0001564590-20-036857-index.htm |
2020-08-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/907654/000156459020039733/0001564590-20-039733-index.htm |
2020-08-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/907654/000156459020042033/0001564590-20-042033-index.htm |
2020-09-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/907654/000156459020044129/0001564590-20-044129-index.htm |
2020-10-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/907654/000156459020045968/0001564590-20-045968-index.htm |
2020-10-28 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/907654/000156459020048346/0001564590-20-048346-index.htm |
2020-10-28 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/907654/000156459020048349/0001564590-20-048349-index.htm |
2020-11-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/907654/000156459020049634/0001564590-20-049634-index.htm |
2020-11-02 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/907654/000156459020049656/0001564590-20-049656-index.htm |
2020-05-20 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/907654/999999999520001219/9999999995-20-001219-index.htm |
2018-05-10 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/907654/999999999718005653/9999999997-18-005653-index.htm |
2019-05-17 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/907654/999999999719004572/9999999997-19-004572-index.htm |
ARCA biopharma, Inc (ABIO) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of ARCA biopharma, Inc (ABIO). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 40%Institutional Ownership: 843%
Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
---|---|---|---|---|---|---|---|---|
2018-02-26 | Anthony A. Jr. Florence | 10% Share Holder | Sell | 1,460,209.00 | 0.50 | 731,272.67 | 0.00 | https://www.sec.gov/Archives/edgar/data/907654/000120919118013932/0001209191-18-013932-index.htm |
2018-04-02 | Brian L. Selby | VP, Finance | Sell | 1,114.00 | 0.50 | 556.33 | 0.00 | https://www.sec.gov/Archives/edgar/data/907654/000120919118023118/0001209191-18-023118-index.htm |
2018-02-26 | DAVID M MOTT | 10% Share Holder | Sell | 1,460,209.00 | 0.50 | 731,272.67 | 0.00 | https://www.sec.gov/Archives/edgar/data/907654/000120919118013936/0001209191-18-013936-index.htm |
2018-02-26 | FOREST BASKETT | 10% Share Holder | Sell | 1,460,209.00 | 0.50 | 731,272.67 | 0.00 | https://www.sec.gov/Archives/edgar/data/907654/000120919118013931/0001209191-18-013931-index.htm |
2018-02-26 | Growth Equity Opportunities IV, LLC | 10% Share Holder | Sell | 1,460,209.00 | 0.50 | 731,272.67 | 0.00 | https://www.sec.gov/Archives/edgar/data/907654/000120919118013927/0001209191-18-013927-index.htm |
2018-02-27 | HEALTHCARE CAPITAL PARTNERS LP VENROCK | 10% Share Holder | Sell | 41,331.00 | 0.53 | 21,905.43 | 0.00 | https://www.sec.gov/Archives/edgar/data/907654/000145817718000001/0001458177-18-000001-index.htm |
2018-02-26 | Jon Sakoda | 10% Share Holder | Sell | 1,460,209.00 | 0.50 | 731,272.67 | 0.00 | https://www.sec.gov/Archives/edgar/data/907654/000120919118013937/0001209191-18-013937-index.htm |
2018-02-26 | JOSHUA MAKOWER | 10% Share Holder | Sell | 1,460,209.00 | 0.50 | 731,272.67 | 0.00 | https://www.sec.gov/Archives/edgar/data/907654/000120919118013935/0001209191-18-013935-index.htm |
2018-02-26 | PETER J BARRIS | 10% Share Holder | Sell | 1,460,209.00 | 0.50 | 731,272.67 | 0.00 | https://www.sec.gov/Archives/edgar/data/907654/000120919118013928/0001209191-18-013928-index.htm |
2018-02-26 | Peter W. Sonsini | 10% Share Holder | Sell | 1,460,209.00 | 0.50 | 731,272.67 | 0.00 | https://www.sec.gov/Archives/edgar/data/907654/000120919118013940/0001209191-18-013940-index.htm |
2018-02-26 | Ravi Viswanathan | 10% Share Holder | Sell | 1,460,209.00 | 0.50 | 731,272.67 | 0.00 | https://www.sec.gov/Archives/edgar/data/907654/000120919118013942/0001209191-18-013942-index.htm |
2018-02-26 | SCOTT D SANDELL | 10% Share Holder | Sell | 1,460,209.00 | 0.50 | 731,272.67 | 0.00 | https://www.sec.gov/Archives/edgar/data/907654/000120919118013939/0001209191-18-013939-index.htm |
2018-02-27 | Brian L. Selby | VP, Finance | Sell | 161.00 | 0.53 | 85.33 | 1,114.00 | https://www.sec.gov/Archives/edgar/data/907654/000120919118015074/0001209191-18-015074-index.htm |
2020-09-21 | ROBERT E CONWAY | Director | Buy | 10,000.00 | 4.77 | 47,660.00 | 11,944.00 | https://www.sec.gov/Archives/edgar/data/907654/000120919120051302/0001209191-20-051302-index.htm |
2018-04-03 | Thomas A Keuer | Chief Operating Officer | Sell | 482.00 | 0.50 | 241.72 | 13,153.00 | https://www.sec.gov/Archives/edgar/data/907654/000120919118023122/0001209191-18-023122-index.htm |
2018-02-28 | Thomas A Keuer | Chief Operating Officer | Sell | 410.00 | 0.72 | 294.38 | 13,635.00 | https://www.sec.gov/Archives/edgar/data/907654/000120919118015077/0001209191-18-015077-index.htm |
2020-09-22 | ROBERT E CONWAY | Director | Buy | 3,056.00 | 4.66 | 14,240.65 | 15,000.00 | https://www.sec.gov/Archives/edgar/data/907654/000120919120051890/0001209191-20-051890-index.htm |
2020-09-25 | ROBERT E CONWAY | Director | Buy | 5,000.00 | 4.28 | 21,399.50 | 20,000.00 | https://www.sec.gov/Archives/edgar/data/907654/000120919120052094/0001209191-20-052094-index.htm |
2018-02-26 | HEALTHCARE CAPITAL PARTNERS LP VENROCK | 10% Share Holder | Sell | 1,500,000.00 | 0.55 | 825,000.00 | 41,331.00 | https://www.sec.gov/Archives/edgar/data/907654/000145817718000001/0001458177-18-000001-index.htm |